Lazard Asset Management’s Syndax Pharmaceuticals SNDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $66K | Buy |
+7,142
| New | +$66K | ﹤0.01% | 1962 |
|
|
2025
Q1 | – | Sell |
-11,602
| Closed | -$153K | – | 2566 |
|
|
2024
Q4 | $153K | Buy |
+11,602
| New | +$153K | ﹤0.01% | 1686 |
|
|
2022
Q2 | – | Sell |
-4,040
| Closed | -$70K | – | 2560 |
|
|
2022
Q1 | $70K | Buy |
4,040
+26
| +0.6% | +$450 | ﹤0.01% | 1566 |
|
|
2021
Q4 | $87K | Buy |
+4,014
| New | +$87K | ﹤0.01% | 1495 |
|